220 related articles for article (PubMed ID: 9251881)
1. Antiemetics revisited.
Roila F; Del Favero A
Curr Opin Oncol; 1997 Jul; 9(4):321-6. PubMed ID: 9251881
[TBL] [Abstract][Full Text] [Related]
2. [Recent improvements in antiemetic therapy].
Roila F; Palladino MA; Ciccarese G; Basurto C
Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
[TBL] [Abstract][Full Text] [Related]
3. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
[TBL] [Abstract][Full Text] [Related]
4. Prevention of chemotherapy- and radiotherapy-induced emesis: results of Perugia Consensus Conference. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC).
Ann Oncol; 1998 Aug; 9(8):811-9. PubMed ID: 9789602
[TBL] [Abstract][Full Text] [Related]
5. New antiemetic drugs.
Roila F; Fatigoni S
Ann Oncol; 2006 Mar; 17 Suppl 2():ii96-100. PubMed ID: 16608997
[TBL] [Abstract][Full Text] [Related]
6. Comparison of oral 5-HT3-receptor antagonists and low-dose oral metoclopramide plus i.m. dexamethasone for the prevention of delayed emesis in head and neck cancer patients receiving high-dose cisplatin.
Mantovani G; Macciò A; Curreli L; Lampis B; Ghiani M; Bianchi A; Contu P
Oncol Rep; 1998; 5(1):273-80. PubMed ID: 9458381
[TBL] [Abstract][Full Text] [Related]
7. [Research on antiemetics: an Italian model of success].
Roila F
Tumori; 1998; 84(1 Suppl):S3-11. PubMed ID: 9617377
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of three 5-HT3 antagonists (granisetron, ondansetron, and tropisetron) plus dexamethasone for the prevention of cisplatin-induced acute emesis: a randomized crossover study.
Chua DT; Sham JS; Kwong DL; Kwok CC; Yue A; Foo YC; Chan R
Am J Clin Oncol; 2000 Apr; 23(2):185-91. PubMed ID: 10776982
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
[TBL] [Abstract][Full Text] [Related]
10. Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilities.
Del Favero A; Roila F; Tonato M
Drug Saf; 1993 Dec; 9(6):410-28. PubMed ID: 7510495
[TBL] [Abstract][Full Text] [Related]
11. Prevention of chemotherapy-induced emesis: the state of the art.
Roila F; Tonato M; Del Favero A
Dig Dis; 1993; 11(6):343-53. PubMed ID: 8306491
[TBL] [Abstract][Full Text] [Related]
12. Drug treatment of chemotherapy-induced delayed emesis.
Tavorath R; Hesketh PJ
Drugs; 1996 Nov; 52(5):639-48. PubMed ID: 9118814
[TBL] [Abstract][Full Text] [Related]
13. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.
Gregory RE; Ettinger DS
Drugs; 1998 Feb; 55(2):173-89. PubMed ID: 9506240
[TBL] [Abstract][Full Text] [Related]
14. 5-HT3-receptor antagonists in the control of delayed-onset emesis.
Gridelli C
Anticancer Res; 2003; 23(3C):2773-82. PubMed ID: 12926112
[TBL] [Abstract][Full Text] [Related]
15. Optimal selection of antiemetics in children receiving cancer chemotherapy.
Roila F; Aapro M; Stewart A
Support Care Cancer; 1998 May; 6(3):215-20. PubMed ID: 9629872
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
[TBL] [Abstract][Full Text] [Related]
17. Antiemetics in children receiving chemotherapy.
Roila F; Feyer P; Maranzano E; Olver I; Clark-Snow R; Warr D; Molassiotis A
Support Care Cancer; 2005 Feb; 13(2):129-31. PubMed ID: 15538642
[TBL] [Abstract][Full Text] [Related]
18. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869.
Van Belle S; Lichinitser MR; Navari RM; Garin AM; Decramer ML; Riviere A; Thant M; Brestan E; Bui B; Eldridge K; De Smet M; Michiels N; Reinhardt RR; Carides AD; Evans JK; Gertz BJ
Cancer; 2002 Jun; 94(11):3032-41. PubMed ID: 12115394
[TBL] [Abstract][Full Text] [Related]
19. Antiemetic agents.
Bleiberg H
Curr Opin Oncol; 1992 Aug; 4(4):597-604. PubMed ID: 1387327
[TBL] [Abstract][Full Text] [Related]
20. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting.
Simpson K; Spencer CM; McClellan KJ
Drugs; 2000 Jun; 59(6):1297-315. PubMed ID: 10882164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
